Galderma Receives FDA Approval for Restylane® Defyne for Chin Augmentation
Galderma announces that the U.S. Food and Drug Administration (FDA) has...
Read MoreGalderma announces that the U.S. Food and Drug Administration (FDA) has...
Read MoreThe U.S. Food and Drug Administration (FDA) has approved Libtayo® (cemiplimab-rwlc) for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates...
Read MoreWhen I announced the Drug Competition Action Plan, or DCAP, in June 2017, I committed the FDA to a number of new steps to increase competition in the market for prescription...
Read MoreAVITA Medical, a global regenerative medicine company, announced that the U.S. Food and Drug Administration (FDA) approved the Company’s Premarket Approval (PMA) application to market the RECELL® Autologous Cell Harvesting...
Read MoreOur most fundamental obligation to the American public is providing patients with access to safe and effective medical products to meet their health care needs as well as protecting them...
Read MoreThe U.S. Food and Drug Administration approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease. The drug is indicated for adults with Fabry disease who...
Read MoreCynosure, Inc. a leader in laser- and light-based aesthetic treatments, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SculpSure™, the...
Read MoreSoolantra® (ivermectin) Cream, 1% found to be well tolerated with powerful results seen as early as two weeks
Read More